Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10

Blood

Volumn 96, Issue 7, 2000, Pages 2568-2573

  Cervenak, L ^a   Morbidelli, L ^a   Donati, D ^a   Donnini, S ^a   Kambayashi, T ^a   Wilson, J L ^a   Axelson, H ^a   Castanos Velez, E ^a   Ljunggren, H G ^a   De Waal Malefyt, R ^a   Granger, H J ^a   Ziche, M ^a   Bejarano, M T ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INTERLEUKIN 10; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BURKITT LYMPHOMA; CARCINOGENICITY; CONTROLLED STUDY; GRAFT REJECTION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL;

EID: 0034307688     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.7.2568.h8002568_2568_2573     Document Type: Article

References (39)

1. Interleukin-10: Biology, role in inflammation and autoimmunity
2. Immunoregulatory role of interleukin 10 in rheumatoid arthritis
3. Attenuation of proinflammatory response by recombinant IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration
4. Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages
5. Potential involvement of IL-10 in suppressing tumor-associated macrophages: Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanisms involving IL-10
6. + T cell clones inhibit antitumor T cell function by secreting IL-10
7. IL-10 inhibits tumor antigen presentation by epidermal antigen presenting cells
8. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells
9. Interleukin-10 transfected into Chinese hamster ovary cells prevents tumor growth and macrophage infiltration
10. Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory
11. Antimetastasic and antitumor activities of interleukin 10 in a murine model of breast cancer
12. Regulation of tumor growth and metastasis by interleukin-10: The melanoma experience
13. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism
14. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice
15. Interleukin-10 inhibits tumor metastasis, downregulates MHC class I, and enhances NK lysis
16. Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibit pro- and anti-inflammatory activity and results in a delayed tumor rejection
17. Interleukin-10 gene transfer inhibits murine mammary tumors and elevates nitric oxide
18. IL-10 inhibition of human prostate PC-3 ML cell metastases in SCID mice: IL-10 stimulation of TIMP-1 and inhibition of MMP-2/MMP-g expression
19. Interleukin 10 (IL-10) inhibition of primary human prostate cell-induced angiogenesis: IL-10 stimulation of tissue inhibitor of metalloproteinase-1 and inhibition of matrix metalloproteinase (MMP)2/MMP-g secretion
20. Establishment in continuous culture of a new type of lymphocyte from a 'Burkitt like' malignant lymphoma (line D.G.-75)
21. SR-alpha promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T cell leukemia virus type 1 long terminal repeat
22. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
23. Role of prostaglandin E1 and copper in angiogenesis
24. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P
25. Venular endothelial cells from bovine heart
26. Burkitt's lymphoma cells reveal different degrees of tumorigenicity in nude mice
27. Involvement Of IL-10 in the autonomous growth of EBV-transformed B cell lines
28. Interteukin-10 abrogates the inhibition of Epstein-Barr virus induced B cell transformation by memory T cell responses
29. Interleukin-10 is a growth factor for human melanoma cells and downregulates HLA class-I, HLA class II and ICAM -1 molecules
30. Down-regulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10
31. Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10
32. Constitutive IL-10 production accounts for the high NK sensitivity, low MHC class I expression, and poor transporter associated with antigen processing (TAP)-1/2 function in the prototype NK target YAC-1
33. Anti-angiogenesis: New concept for therapy of solid tumors
34. Angiogenesis in cancer, vascular, rheumatoid, and other disease
35. Intratumoral microvessel density as a prognostic factor in cancer
36. Macrophages and angiogenesis
37. TGF-α1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells
38. Contribution of natural killer cells to inhibition of angiogenesis by IL-12
39. Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice